Published in Auton Autacoid Pharmacol on September 28, 2011
OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. J Pharmacol Exp Ther (1998) 1.74
Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet (1999) 1.61
Identification of three human type-II classic cadherins and frequent heterophilic interactions between different subclasses of type-II classic cadherins. Biochem J (2000) 1.41
Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors. Jpn J Pharmacol (1999) 1.41
alpha-Glucosidase inhibitory activity of the methanolic extract from Tournefortia hartwegiana: an anti-hyperglycemic agent. J Ethnopharmacol (2006) 1.39
Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol (1996) 1.38
Primary structure and gene localization of human prolidase. J Biol Chem (1989) 1.37
Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents. Nature (1994) 1.37
KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues. Mol Pharmacol (1995) 1.34
Cloning, functional expression and tissue distribution of human cDNA for the alpha 1C-adrenergic receptor. Biochem Biophys Res Commun (1993) 1.25
MCM3AP, a novel acetyltransferase that acetylates replication protein MCM3. EMBO Rep (2001) 1.23
Differential subcellular localization of DNA-dependent protein kinase components Ku and DNA-PKcs during mitosis. J Cell Sci (1999) 1.15
Prolonged hyporesponsiveness of vascular smooth muscle contraction after halothane anesthesia in rabbits. Anesth Analg (1985) 1.13
Selective production of transgenic mice using green fluorescent protein as a marker. Nat Biotechnol (1997) 1.09
Molecular monitoring of bleomycin-induced pulmonary fibrosis by cDNA microarray-based gene expression profiling. Biochem Biophys Res Commun (2001) 1.09
Use of recombinant alpha 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy. Eur J Pharmacol (1995) 1.08
Alpha 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy. Br J Pharmacol (1996) 1.06
Alpha1-adrenoceptors are required for normal male sexual function. Br J Pharmacol (2007) 1.05
Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human prostate: comparison of benign hypertrophied tissue and non-hypertrophied tissue. Br J Pharmacol (1996) 1.05
Characterization of calcium signaling by purinergic receptor-channels expressed in excitable cells. Mol Pharmacol (2000) 1.03
Subtype-specific differences in subcellular localization of alpha1-adrenoceptors: chlorethylclonidine preferentially alkylates the accessible cell surface alpha1-adrenoceptors irrespective of the subtype. Mol Pharmacol (1997) 1.03
Age-related decrease in beta adrenergic receptor-mediated vascular smooth muscle relaxation. J Pharmacol Exp Ther (1986) 1.01
Cardiomyopathy in a rat model of pheochromocytoma. Morphological and functional alterations. Am J Cardiovasc Pathol (1988) 1.01
Identification of a novel MCM3-associated protein that facilitates MCM3 nuclear localization. J Biol Chem (1998) 1.01
Cloning, functional expression and tissue distribution of human alpha 1c-adrenoceptor splice variants. FEBS Lett (1995) 1.01
Desensitization of beta-adrenergic receptors by pheochromocytoma. Endocrinology (1984) 1.00
Correlation between phosphatidylinositol labeling and contraction in rabbit aorta: effect of alpha-1 adrenergic activation. J Pharmacol Exp Ther (1982) 0.95
Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes Obes Metab (2008) 0.95
Cloning of the human alpha 1d-adrenergic receptor and inducible expression of three human subtypes in SK-N-MC cells. Mol Pharmacol (1995) 0.95
Novel green fluorescent protein-based ratiometric indicators for monitoring pH in defined intracellular microdomains. Biochem Biophys Res Commun (2001) 0.94
Alpha 1-adrenoceptors: subtypes, signaling, and roles in health and disease. Arch Med Res (2000) 0.94
Desensitization of alpha-1 adrenergic receptor-mediated vascular smooth muscle contraction. J Pharmacol Exp Ther (1985) 0.93
Quantification and distribution of alpha 1-adrenoceptor subtype mRNAs in human vas deferens: comparison with those of epididymal and pelvic portions. Br J Pharmacol (1997) 0.92
Quantification and distribution of alpha1-adrenoceptor subtype mRNAs in human proximal urethra. Br J Pharmacol (1998) 0.92
Biochemical basis of prolidase deficiency. Polypeptide and RNA phenotypes and the relation to clinical phenotypes. J Clin Invest (1990) 0.90
Roles of alpha 1- and beta-adrenergic receptors in adrenergic responsiveness of liver cells formed after partial hepatectomy. Biochim Biophys Acta (1983) 0.89
Targeting activation-induced cytidine deaminase prevents colon cancer development despite persistent colonic inflammation. Oncogene (2011) 0.89
Distribution and developmental change of vasopressin V1A and V2 receptor mRNA in rats. Eur J Pharmacol (1994) 0.89
Two pharmacologically distinct alpha 1-adrenoceptor subtypes in the contraction of rabbit aorta: each subtype couples with a different Ca2+ signalling mechanism and plays a different physiological role. Mol Pharmacol (1990) 0.89
Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation. Br J Cancer (2007) 0.88
Structural organization and analysis of the human fumarylacetoacetate hydrolase gene in tyrosinemia type I. Biochim Biophys Acta (1994) 0.88
Differential response to chloroethylclonidine in blood vessels of normotensive and spontaneously hypertensive rats: role of alpha 1D- and alpha 1A-adrenoceptors in contraction. Br J Pharmacol (2000) 0.87
Real-time optical monitoring of ligand-mediated internalization of alpha1b-adrenoceptor with green fluorescent protein. Mol Endocrinol (1998) 0.87
Cloning, functional expression and tissue distribution of human cDNA for the vascular-type vasopressin receptor. Biochem Biophys Res Commun (1994) 0.87
Evidence for an age-dependent functional expression of alpha 1D-adrenoceptors in the rat vasculature. Eur J Pharmacol (1997) 0.87
Identification of the sequence responsible for the nuclear localization of human Cdc6. FEBS Lett (1999) 0.87
Hyperbaric exposure with high oxygen concentration inhibits growth-associated increase in the glucose level of diabetic Goto-Kakizaki rats. Diabetes Obes Metab (2006) 0.87
Effect of L-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats. Clin Neuropharmacol (1997) 0.87
Selectivity of the imidazoline alpha-adrenoceptor agonists (oxymetazoline and cirazoline) for human cloned alpha 1-adrenoceptor subtypes. Br J Pharmacol (1995) 0.86
Hamster alpha 1B-adrenergic receptor directly activates Gs in the transfected Chinese hamster ovary cells. Mol Pharmacol (1995) 0.86
Effects of running exercise on fibre-type distribution of soleus and plantaris muscles in diabetic Otsuka Long-Evans Tokushima fatty rats. Diabetes Obes Metab (2006) 0.86
Simultaneous determination of metoprolol and alpha-hydroxymetoprolol in human plasma and urine by liquid chromatography with a preliminary observation on metoprolol oxidation in Japanese subjects. Ther Drug Monit (1988) 0.85
Identification of alpha 1 adrenergic receptors in rabbit aorta with [125I] BE2254. Life Sci (1984) 0.85
The pharmacological profile of cloned and stably expressed alpha 1b-adrenoceptor in CHO cells. Eur J Pharmacol (1994) 0.85
Desensitization of postjunctional alpha 1- and alpha 2-adrenergic receptor-mediated vasopressor responses in rat harboring pheochromocytoma. Circ Res (1987) 0.84
Oxytocin receptors expressed and coupled to Ca2+ signalling in a human vascular smooth muscle cell line. Br J Pharmacol (1996) 0.84
Alpha1A-adrenoceptors predominate in the control of blood pressure in mouse mesenteric vascular bed. Auton Autacoid Pharmacol (2007) 0.84
Epinephrine infusion induces hyporesponsiveness of vascular smooth muscle. Life Sci (1985) 0.84
Distribution of geriatric disease-related genotypes in the National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS-LSA). J Epidemiol (2000) 0.84
Automated DNA fragment collection by capillary array gel electrophoresis in search of differentially expressed genes. Electrophoresis (2000) 0.83
NS-49, a novel alpha 1a-adrenoceptor-selective agonist characterization using recombinant human alpha 1-adrenoceptors. Eur J Pharmacol (1995) 0.83
Identification of alpha 1C-adrenergic receptor mRNA in bovine retinal pigment epithelium. Invest Ophthalmol Vis Sci (1993) 0.83
Sensitivity of liver cells formed after partial hepatectomy to glucagon, vasopressin and angiotensin II. Biochim Biophys Acta (1983) 0.83
Distribution and developmental changes in vasopressin V2 receptor mRNA in rat brain. Differentiation (1995) 0.83
Interaction of the alpha(1B)-adrenergic receptor with gC1q-R, a multifunctional protein. J Biol Chem (1999) 0.83
Cycloheximide: an adrenergic agent. Life Sci (1982) 0.82
Characterization of a point mutation in the pyruvate dehydrogenase E1 alpha gene from two boys with primary lactic acidaemia. J Inherit Metab Dis (1994) 0.82
Spatial and temporal regulation of protein expression by bldA within a Streptomyces lividans colony. FEBS Lett (1999) 0.82
Altered responsiveness to alpha- and beta-adrenoceptor stimulation in hepatocytes cultured in defined medium. Biochem Pharmacol (1986) 0.82
Modulation of the arterial baroreceptor reflex by the vasopressin receptor in the area postrema of the hypertensive rats. Neurosci Lett (1997) 0.82
Detection of alpha 1-adrenoceptor subtypes in human hypertrophied prostate by in situ hybridization. Histochem J (1996) 0.82
Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes. Br J Pharmacol (2000) 0.82
Postjunctional alpha1-adrenoceptors in the vasculature of the pithed mouse are of the alpha1A-subtype. Auton Autacoid Pharmacol (2005) 0.82
Effects of pheochromocytoma on cardiovascular alpha adrenergic receptor system. Heart Vessels (1985) 0.82
Desensitization of beta-adrenergic receptor-mediated vascular smooth muscle relaxation. Mol Pharmacol (1985) 0.82
Structure and sequence of the mouse V1a and V1b vasopressin receptor genes. Jpn J Pharmacol (1999) 0.82
Effects of quinidine and verapamil on human cardiovascular alpha1-adrenoceptors. Circulation (1998) 0.82
Effects of castration on contraction and alpha(1)-adrenoceptor expression in rat prostate. Br J Pharmacol (2000) 0.81
Differential mechanism for the cell surface sorting and agonist-promoted internalization of the alpha1B-adrenoceptor. Br J Pharmacol (1998) 0.81
Changes in mitochondrial functionality and calcium uptake in hypertensive rats as a function of age. Mitochondrion (2008) 0.81
Evidence that endogenous inosine and adenosine-mediated hyperglycaemia during ischaemia-reperfusion through A3 adenosine receptors. Auton Autacoid Pharmacol (2009) 0.81
Distribution of alpha1-adrenoceptor subtype mRNA and identification of subtype responsible for renovascular contraction in human renal artery. Life Sci (2000) 0.81
Immunoaffinity purification of human erythrocyte prolidase. Clin Chim Acta (1988) 0.81
Characterization of the mouse alpha1D-adrenergic receptor gene. Jpn J Pharmacol (1999) 0.81
Parallel regulation of mitogen-activated protein kinase kinase 3 (MKK3) and MKK6 in Gq-signaling cascade. J Biol Chem (2001) 0.81
Captopril therapy decreases both expression and function of alpha-adrenoceptors in pre- hypertensive rat aorta. Auton Autacoid Pharmacol (2006) 0.81
Increased sensitivity to oxidative stress and the loss of muscarinic receptor responsiveness in senescence. Ann N Y Acad Sci (1996) 0.81
Regulation of the rate of synthesis of nitric oxide by Mg(2+) and hypoxia. Studies in rat heart mitochondria. Amino Acids (2002) 0.80
Genomic analysis of a mouse model of immunoglobulin A nephropathy reveals an enhanced PDGF-EDG5 cascade. Pharmacogenomics J (2001) 0.80
Involvement of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase in alpha1B-adrenergic receptor/Galphaq-induced inhibition of cell proliferation. Biochem Biophys Res Commun (2001) 0.80
Both alpha(1A)- and alpha(1B)-adrenergic receptor subtypes couple to the transient outward current (I(To)) in rat ventricular myocytes. Br J Pharmacol (2000) 0.80
Alpha 1-adrenoceptor subtypes in aorta (alpha 1A) and liver (alpha 1B). Eur J Pharmacol (1991) 0.80
Beta2-adrenergic receptor/cyclic adenosine monophosphate (cAMP) leads to JNK activation through Rho family small GTPases. Biochem Biophys Res Commun (2001) 0.80
Negative chronotropic effect of endothelin 1 mediated through ETA receptors in guinea pig atria. Circ Res (1995) 0.80